A Phase II Study of Oxaliplatin, Dose-Intense Capecitabine and High-Dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer

BACKGROUND: This study was designed to determine the efficacy and tolerability of a novel two-week regimen of capecitabine, oxaliplatin and bevacizumab in patients with chemo-naive advanced colorectal cancer. PATIENTS AND METHODS: Nineteen patients with previously untreated advanced colorectal cance...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wong, Nan Soon, Fernando, Nishan H., Bendell, Johanna C., Morse, Michael A., Blobe, Gerard C., Honeycutt, Wanda, Pang, Herbert, Hurwitz, Herbert I.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4120818/
https://ncbi.nlm.nih.gov/pubmed/21855046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2011.03.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados